Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity (Q39463659)

From Wikidata

Jump to navigation Jump to search

scientific article published on 4 October 2011

Language	Label	Description	Also known as
English	Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity	scientific article published on 4 October 2011

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Optimized quantities of GDNF overexpressed by engineered astrocytes are critical for protection of neuroblastoma cells against 6-OHDA toxicity (English)

1 reference

Europe PubMed Central

12 September 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Roya Safi

1

1 reference

Europe PubMed Central

12 September 2017

Mossa Gardaneh

2

1 reference

Europe PubMed Central

12 September 2017

Yasin Panahi

3

1 reference

Europe PubMed Central

12 September 2017

Nader Maghsoudi

4

1 reference

Europe PubMed Central

12 September 2017

Mohammad Zaefizadeh

5

1 reference

Europe PubMed Central

12 September 2017

Ehsan Gharib

6

1 reference

Europe PubMed Central

12 September 2017

publication date

4 October 2011

1 reference

Europe PubMed Central

12 September 2017

Journal of Molecular Neuroscience

1 reference

Europe PubMed Central

12 September 2017

46

1 reference

Europe PubMed Central

12 September 2017

3

1 reference

Europe PubMed Central

12 September 2017

654-665

1 reference

Europe PubMed Central

12 September 2017

https://scigraph.springernature.com/pub.10.1007/s12031-011-9654-8

0 references

The GDNF family: signalling, biological functions and therapeutic value

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Motoneurons crave glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Neurons depend on astrocytes in a coculture system for protection from glutamate toxicity.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF treatment in Parkinson's disease: time for controlled clinical trials?

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Ontogeny and distribution of glial cell line-derived neurotrophic factor (GDNF) mRNA in rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Emerging restorative treatments for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte protection of neurons: role of transforming growth factor-beta signaling via a c-Jun-AP-1 protective pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Glutathione pathways in the brain.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Long-term restoration of nigrostriatal system function by implanting GDNF genetically modified fibroblasts in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Ex vivo gene delivery of GDNF using primary astrocytes transduced with a lentiviral vector provides neuroprotection in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Grafts of extra-adrenal chromaffin cells as aggregates show better survival rate and regenerative effects on parkinsonian rats than dispersed cell grafts

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF delivery using human neural progenitor cells in a rat model of ALS.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intracerebral infusion of glial cell line-derived neurotrophic factor promotes striatal neurogenesis after stroke in adult rats

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Cloning and structural organization of the gene encoding the mouse glial cell line-derived neurotrophic factor, GDNF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intramuscular grafts of myoblasts genetically modified to secrete glial cell line-derived neurotrophic factor prevent motoneuron loss and disease progression in a mouse model of familial amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Convective delivery of glial cell line-derived neurotrophic factor in the human putamen

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Promotion of survival and regeneration of nigral dopamine neurons in a rat model of Parkinson's disease after implantation of embryonal carcinoma-derived neurons genetically engineered to produce glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte-derived transgene GDNF promotes complete and long-term survival of adult facial motoneurons following avulsion and differentially regulates the expression of transcription factors of AP-1 and ATF/CREB families

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Microcapsules prepared with different biomaterials to immobilize GDNF secreting 3T3 fibroblasts

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Long-term striatal overexpression of GDNF selectively downregulates tyrosine hydroxylase in the intact nigrostriatal dopamine system

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6OHDA cytotoxicity

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Novel functions and signalling pathways for GDNF.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Viral vectors, animal models and new therapies for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Crossroads in GDNF therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Unilateral intraputamenal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Targets for neuroprotection in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Pitx3-transfected astrocytes secrete brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor and protect dopamine neurons in mesencephalon cultures

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Overexpression of glial cell line-derived neurotrophic factor in the CNS rescues motoneurons from programmed cell death and promotes their long-term survival following axotomy

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Astrocyte-conditioned medium protecting hippocampal neurons in primary cultures against corticosterone-induced damages via PI3-K/Akt signal pathway.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-011-9654-8

21 January 2018

Neuroprotection through delivery of glial cell line-derived neurotrophic factor by neural stem cells in a mouse model of Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

GDNF delivery for Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotrophic effects of L-DOPA in postnatal midbrain dopamine neuron/cortical astrocyte cocultures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Astrocytes protect oligodendrocyte precursor cells via MEK/ERK and PI3K/Akt signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuronal vulnerability in Parkinson's disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotrophic effects of conditioned media of astrocytes isolated from different brain regions on hippocampal and cortical neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/21969113

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12031-011-9654-8

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39463659&oldid=1829416030"